Nimbus site 122 — Rockville, Maryland

Nimbus site 122 is a clinical research site located in Rockville, Maryland, United States 20850.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Nimbus site 122 has participated in 1 clinical trials.

Therapeutic areas: Moderate to Severe Plaque Psoriasis.

Sponsors: Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockville

Browse all research sites in Maryland · View every site in Rockville

• Holy Cross Hospital
• Cardiac Associates, Shady Grove Adventist Hospital
• Biostatistics Center, George Washington University
• Safe Concussion Outcome Recovery & Education (SCORE) Clinic at Children's National Hospital
• George Washington University Biostatistics Center, Suite 750, 6110 Executive Blvd
• George Washington University Biostatistics Center
• Shady Grove Adventist Hospital
• Center for Autism Spectrum Disorders, Children's National Hospital
• George Washington University
• Research Site
• Novo Nordisk Investigational Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nimbus site 122?

Nimbus site 122 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nimbus site 122 conducted?

Nimbus site 122 has 1 clinical trials on record. Their work covers Moderate to Severe Plaque Psoriasis.

Is Nimbus site 122 accredited by Crixeo Clinical Trials?

Nimbus site 122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nimbus site 122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.